pathway Info Card

Response To Tacrolimus

Information about Response To Tacrolimus: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Response To Tacrolimus

Most recent studies have shown that Response To Tacrolimus shares some biological mechanisms with drug-resistance, excretion, exocytosis, pigmentation, transport, urea-transport, vasoconstriction.

Among the many pathways, these few ones have gauged particular interests from scientists studying Response To Tacrolimus, and have been seen in publications frequently: drug-resistance, excretion, exocytosis, pigmentation, transport, urea-transport, vasoconstriction

Quite a number of genes have been found to play important roles in Response To Tacrolimus, such as AKR1B1, AREG, CABIN1, CD19, CD28, CHKA, CTLA4, CYP3A5, FDXR, IL2, IL2RA, IL4, INS, ISG20, NOD2, Tnfrsf13c. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.

Response To Tacrolimus Related Genes

click to see detail information for each gene

AKR1B1	AREG	CABIN1
CD19	CD28	CHKA
CTLA4	CYP3A5	FDXR
IL2	IL2RA	IL4
INS	ISG20	NOD2
Tnfrsf13c

Diseases Related to Response To Tacrolimus

This information is being compiled and will come in a future update

autoimmune diseases	autoimmune reaction	colitis
dermatitis	dermatologic disorders	diarrhea
gingival hyperplasia	granuloma	intestinal diseases
kidney diseases	lichen disease	lichen planus
lung diseases	myasthenias	nephropathy toxic

Related pathways

drug resistance	excretion	exocytosis
pigmentation	transport	urea transport
vasoconstriction